Moreover, the fatty acid transporter sCD36 has been considered a potential biomarker of atherosclerosis given that, as mentioned before in animal models of atherosclerosis, absence of CD36 has been reported to result in a reduction of atherosclerosis [8]. Here, CD36 is linked to atherosclerosis.